Viveve Medical, Inc.
Viveve Medical, Inc. (VIVE) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · VIVE · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
VIVE insider trading · insider activity
Source: SEC Form 4
6
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
JORN DEBORA director | Jan 4, 2022 | Award | 22,000 | $1.26 | $27.7K | 22.0K | Form 4 ↗ |
Morris Arlene director | Jan 4, 2022 | Award | 22,000 | $1.26 | $27.7K | 22.0K | Form 4 ↗ |
Presnell Sharon Collins director | Jan 4, 2022 | Award | 18,000 | $1.26 | $22.7K | 18.0K | Form 4 ↗ |
Robbins Jim B SVP, Finance & Administration | Jan 4, 2022 | Award | 42,000 | $1.26 | $52.9K | 42.0K | Form 4 ↗ |
Basta Steven L director | Jan 4, 2022 | Award | 48,000 | $1.26 | $60.5K | 48.0K | Form 4 ↗ |
Durbin Scott Chief Executive Officer | Jan 4, 2022 | Award | 258,000 | $1.26 | $325.1K | 258.0K | Form 4 ↗ |
Basta Steven L director | Dec 15, 2021 | D-Return | 28 | $1.41 | $39.48 | 25 | Form 4 ↗ |
Durbin Scott Chief Executive Officer | Dec 15, 2021 | D-Return | 2 | $1.40 | $2.8 | 10 | Form 4 ↗ |
Robbins Jim B SVP, Finance & Administration | Dec 15, 2021 | D-Return | 36 | $1.43 | $51.48 | 0 | Form 4 ↗ |
Basta Steven L director | Jun 23, 2021 | Award | 116,200 | $2.73 | $317.2K | 116.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Viveve Medical, Inc. (VIVE) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold VIVE stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
VIVE ownershipViveve Medical, Inc. (VIVE) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.